Central blood pressure lowering effect of telmisartan‐rosuvastatin single‐pill combination in hypertensive patients combined with dyslipidemia: A pilot study

Abstract This multicenter, phase 4, Prospective Randomized Open, Blinded End‐point (PROBE) study aimed to evaluate safety and efficacy of telmisartan/rosuvastatin single‐pill combination (SPC) therapy on lowering central blood pressure (BP) compared with telmisartan monotherapy in hypertensive patie...

Full description

Bibliographic Details
Published in:The Journal of Clinical Hypertension
Main Authors: JungMin Choi, Ki‐Chul Sung, Sang‐Hyun Ihm, Chang‐Hwan Yoon, Seung Woo Park, Sung‐Ha Park, Jang‐Young Kim, Sung‐Uk Kwon, Hae‐Young Lee
Format: Article
Language:English
Published: Wiley 2021-09-01
Subjects:
angiotensin II receptor blocker
dyslipidemia
hypertension
rosuvastatin
telmisartan
Online Access:https://doi.org/10.1111/jch.14345

Internet

https://doi.org/10.1111/jch.14345

Similar Items